ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1017

A Novel Mechanism of Arthritis-Induced Pain: Activation of Sensory Neurons By Autoantibodies

Duygu Bas1, Alex Bersellini Farinotti1, Jon Sinclair2, Gustaf Wigerblad3, Kutty Selva Nandakumar4, Rikard Holmdahl5, Bo Rydqvist2 and Camilla Svensson3, 1Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden, 2Karolinska Institutet, Stockholm, Sweden, 3Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden, 4Department of Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden, 5Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: autoantibodies and pain, Fc receptors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Pain: Basic Aspects

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Joint pain is one of the main reasons for patients with rheumatoid arthritis (RA) to seek medical care. Collagen type II (CII) antibodies (Abs) are detectable in serum and synovial fluid of many RA patients and are thought to contribute to the inflammatory process in the joint. A common view is that factors produced during inflammation are the major cause of joint pain in RA. However, pain can appear prior to diagnosis and continue to be a significant problem even when the disease is under medical control. Earlier, we have shown that while injection of CII Abs in mice induces transient joint inflammation, pain-like behavior not only outlasts the inflammation but also precedes the onset of inflammation. Moreover, Fc gamma receptors (FcγRs), which are activated by immune complexes (ICs) on inflammatory cells, are also present on peripheral sensory neurons. The aim of this study is to examine if antibodies can directly activate sensory neurons via neuronally expressed FcγRs and thus act as pain-inducing molecules.

Methods: Male BALB/c mice (10-12 weeks) were used to prepare dorsal root ganglia (DRG) primary neuronal cell cultures. Neuronal expression of FcγRI was evaluated by immunocytochemistry. The effect of stimulation with CII mAb cocktail, control IgG2b and CII (all 1 μg/ml) and ICs formed by CII mAb cocktail and CII (CII-IC; 0.1-10 µg/ml) on neuronal excitability were examined by a) calcitonin-gene related peptide (CGRP) release in wild type (WT) and Fcγ-chain deficient mice b) electrophysiology and c) calcium imaging

Results: FcγRI expression was detected in DRG neurons and co-localized with PGP9.5, a neuronal marker. The levels of CGRP, a pain-associated neurotransmitter were increased in a bell shaped fashion in supernatants from WT DRG neurons stimulated with CII-IC, peaking at 1 µg/ml. Note that, 1 µg/ml concentration was used in subsequent studies. No increase in CGRP was detected after stimulation with CII mAb cocktail, CII or control IgG2b. CGRP release was induced by capsaicin (Cap; 50 nM), a ligand for transient receptor potential vanilloid 1 (TRPV1), was used as a positive control. In contrast, while DRG cultures from Fcγ-chain deficient mice responded to Cap, stimulation with CII-IC did not evoke CGRP release. Electrophysiological recordings in voltage clamp mode showed ionic current changes in the presence of CII-IC. Of 114 cells, 52 cells gave inward current response to Cap and 42% (22) of the Cap+ cells gave response to CII-IC. In control experiments, none of the Cap+ cells (18) responded to IgG2b. Calcium influx assessed by calcium imaging increased in DRG neurons stimulated with CII-IC and KCl (50 mM) (positive control to detect functional neurons) but not control IgG2b. Among the 1555 cells, 1119 cells gave response to KCl and 22.1% (247) of the KCl+ cells responded to CII-IC, but not to control IgG2b (<1%). 

Conclusion: The present study demonstrates for the first time that CII Abs in immune complex formation, presumably via activation of FcγRs expressed on DRG neurons directly contribute to nociception. These findings have the potential to define new roles for antibodies in pain transmission and open new avenues for treatment of pain in RA and other autoimmune diseases.


Disclosure: D. Bas, None; A. Bersellini Farinotti, None; J. Sinclair, None; G. Wigerblad, None; K. S. Nandakumar, None; R. Holmdahl, None; B. Rydqvist, None; C. Svensson, None.

To cite this abstract in AMA style:

Bas D, Bersellini Farinotti A, Sinclair J, Wigerblad G, Nandakumar KS, Holmdahl R, Rydqvist B, Svensson C. A Novel Mechanism of Arthritis-Induced Pain: Activation of Sensory Neurons By Autoantibodies [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/a-novel-mechanism-of-arthritis-induced-pain-activation-of-sensory-neurons-by-autoantibodies/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-novel-mechanism-of-arthritis-induced-pain-activation-of-sensory-neurons-by-autoantibodies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology